Rendon, Yvette Maris .

HRN: 27-86-16  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/12/2025
AMPICILLIN 1GM (VIAL)
10/12/2025
10/19/2025
IV
2 Grams
Q6
Prom X5 Hrs
Checking Final Appropriateness 
10/12/2025
CEFUROXIME 500MG (TAB)
10/12/2025
10/18/2025
ORAL
500mg
2 Times A Day
Premature Rupture Of Membranes
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: